Maximal androgen blockade for the treatment of metastatic prostate cancer—a systematic review

INTRODUCTION: Maximal androgen blockade (mab) versus castration alone in patients with metastatic prostate cancer has been extensively evaluated in randomized trials. The inconsistent results have led to the publication of multiple meta-analyses. The present review examines the evidence from meta-an...

Descripción completa

Detalles Bibliográficos
Autores principales: Lukka, H., Waldron, T., Klotz, L., Winquist, E., Trachtenberg, J.
Formato: Texto
Lenguaje:English
Publicado: Multimed Inc. 2006
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1891181/
https://www.ncbi.nlm.nih.gov/pubmed/17576447

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1891181/
https://www.ncbi.nlm.nih.gov/pubmed/17576447

Ejemplares similares